4520
4521
4522
4523
4524
4525
4526
4527
4528
4529
4530
4531
4532
4533
4534
4535
4536
4537
4538
Home
En
中文
WebSite
> New Products
New Products
4520
4521
4522
4523
4524
4525
4526
4527
4528
4529
4530
4531
4532
4533
4534
4535
4536
4537
4538
1807809-74-0
4-[4-(2-Fluoroethyl)-1-piperazinyl]-2-methoxyaniline
1351470-17-1
Setoxaximab
1648796-29-5
Gimsilumab
1043556-46-2
Gantenerumab
1345009-45-1
Vantictumab
2019133-28-7
Zagotenemab
1607793-29-2
Faricimab
1259366-27-2
Methyl (2R,3R)-rel-3-Aminobicyclo[2.2.1]heptane-2-carboxylate
2055640-86-1
Mitazalimab
1781223-80-0
Telisotuzumab
1073538-99-4
Timolumab
1186098-83-8
Oxelumab
1204390-13-5
Dusigitumab
1806849-64-8
5-Bromo-6-fluoropicolinonitrile
1182724-82-8
7-Bromodibenzo[f,h]quinoxaline
1879918-31-6
Loncastuximab Tesirine
2056878-75-0
Osocimab
1685249-67-5
Losatuxizumab Vedotin
2043952-59-4
Abrezekimab
1801544-27-3
Losatuxizumab
1446419-85-7
Evinacumab
1784576-75-5
2-Methoxycyclopropanecarbaldehyde
2052649-42-8
Samrotamab Vedotin
1256258-86-2
Inclacumab
1939109-24-6
Berlimatoxumab
2094516-02-4
Cinpanemab
953400-68-5
Lebrikizumab
823788-82-5
HuCC49
1350624-75-7
Margetuximab
2148334-68-1
Tamrintamab Pamozirine
921618-45-3
Camidanlumab
2171765-46-9
2-(Fmoc-amino)-3-mercapto-3-methylbutanoic Acid
1227623-09-7
1,8-Naphthyridine-2-boronic Acid
7377-53-9
CAPRYLOHYDROXAMIC ACID
2044984-83-8
Etigilimab
1156467-77-4
6-Bromo-3-oxoindane-5-carbonitrile
1094438-61-5
5-Bromo-2-ethoxybenzyl Bromide
103307-09-1
2,3-diphenyldibenzoquinoxaline
2135632-29-8
Atoltivimab
1791420-09-1
Dilpacimab
748817-16-5
N-(10-Aminodecyl)-5-[(3aS,4S,6aR)-2-oxohexahydro-4-thieno[3,4-d]imidazolyl]pentanamide 2,2,2-Trifluoroacetate
1831098-91-9
Duvortuxizumab
1312797-14-0
Parsatuzumab
1884306-01-7
cis-N1-(2-Fluoroethyl)-1,4-cyclohexanediamine
868747-45-9
Cantuzumab Ravtansine
357613-86-6
Lumiliximab
1312305-12-6
Vofatamab
1469876-18-3
Labetuzumab Govitecan
674782-26-4
Leronlimab
1824315-26-5
2-Chloro-4-cyclopropyl-6,7-dihydro-5H-cyclopenta[d]pyrimidine
2084037-83-0
Quetmolimab
1421830-13-8
Lulizumab Pegol
2287344-70-9
1-(Chloromethyl)-3-(3-fluorophenyl)bicyclo[1.1.1]pentane
1613313-09-9
Rovalpituzumab Tesirine
569658-80-6
Exbivirumab
1610761-46-0
Plozalizumab
1352734-32-7
5-Methylisoxazole-3-boronic Acid Pinacol Ester
1952272-74-0
Bemarituzumab
1931944-80-7
Donanemab
915296-00-3
Elotuzumab
1509916-03-3
Cergutuzumab Amunaleukin
1846569-07-0
Tributyl(5-ethyl-2-furyl)stannane
1393659-46-5
Diridavumab
1417318-27-4
Utomilumab
1673516-98-7
Relatlimab
1939108-95-8
Atidortoxumab
1929549-92-7
Ianalumab
1808081-43-7
Gilvetmab
1826819-57-1
Azintuxizumab
1709815-23-5
Emapalumab
1684393-04-1
Rosmantuzumab
1640971-88-5
Lupartumab
1629615-23-1
Suptavumab
1627519-84-9
Rivabazumab
1233953-61-1
Refanezumab
1418731-10-8
Tisotumab Vedotin
1228763-95-8
Monalizumab
1453362-90-7
Lutetium (177Lu) Lilotomab Satetraxetan
1531589-13-5
Brolucizumab
1403744-56-8
Begelomab
1442657-12-6
Pasotuxizumab
1346452-25-2
Enfortumab Vedotin
1243266-04-7
Tovetumab
1326244-10-3
Tildrakizumab
1318075-13-6
Simtuzumab
1245634-25-6
Actoxumab
915810-67-2
Caplacizumab
1178862-65-1
Ponezumab
1044758-60-2
Etrolizumab
914257-21-9
Suvizumab
1007106-86-6
Fezakinumab
476413-07-7
Yttrium (90Y) Tacatuzumab Tetraxetan
1020748-57-5
Moxetumomab Pasudotox
2246363-09-5
8-Chloro-7-fluoro-6-iodoisoquinolin-3-amine
1643796-25-1
Benzyl (2-Bromo-5-fluorophenyl)carbamate
95932-42-6
tert-Butyl [3-(Hydroxymethyl)phenyl] Carbonate
2098029-44-6
1-Boc-3-[(4-ethynyl-1-pyrazolyl)methyl]azetidine
2091591-51-2
3-Chloro-5-methoxy-2-nitroaniline
1147422-36-3
1-(4-Piperidyl)azetidin-2-one
1785079-90-4
4-(2-Fluoroethyl)cyclohexanamine
MSDS
|
CAS
|
CAS DataBase
|
Pricacy
|
Terms
|
About Us
|
New Products
|
Contact us
|
Computer Version
Chemical Book